Skip to content

Efficacy and safety of compound heparin sodium Allantoin gel in the treatment of rosacea

Efficacy and safety of compound heparin sodium Allantoin gel in the treatment of rosacea

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087948
Enrollment
Unknown
Registered
2024-08-07
Start date
2023-04-26
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Group I:Compound heparin sodium Allantoin gel
Group II:HA emulsion

Sponsors

The Second Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: ? 18-60 year old patients with rosacea who meet the diagnostic criteria for rosacea in China 2021 with persistent erythema and papules/pustules ? Facial dermatoscopy shows characteristic changes in rosacea; ? No liver and kidney function abnormality, metabolic abnormality and Skeleton disease; ? No antibiotic treatment in the past 3 months; ? Sign an informed consent form and strictly adhere to the treatment plan.

Exclusion criteria

Exclusion criteria: ? Those who are currently pregnant or breastfeeding, or have a pregnancy plan within six months; ? Allergic to Hydroxychloroquine or Clindamycin hydrochloride or compound heparin sodium Allantoin gel Topical medication; ? Other serious systemic diseases such as malignant tumors and psychological disorders; ? Patients who cannot take Clindamycin hydrochloride and retinoic acid for other reasons; ? People who suffer from diseases due to repeated use of immune drugs or Corticosteroid or immune dysfunction. ? Patients who do not cooperate or have poor compliance.

Design outcomes

Primary

MeasureTime frame
Clinician’serythemaassessment,CEA;TransepidermalWaterLoss;Stratum Corneum Hydration;

Secondary

MeasureTime frame
Investigator’sglobalassessment,IGA;Rosacea Quality of Life Index(RQoL);Global Aesthetic Improvement Scale(GAIS);Patient’s self-assessment,PSA;Subject Satisfaction Scale(SSS);

Countries

China

Contacts

Public ContactJiawen Wu

The Second Affiliated Hospital of Xi'an Jiaotong University

jiawen702@126.com+86 137 7253 7391

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026